Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-25

Clinical Trial Update: Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial update assessing liraglutide's impact on blood glucose control in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liraglutide (Victoza) (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED